Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
Influence of acute normobaric hypoxia on physiological variables and lactate turn point determination in trained men.

Journal of sports science & medicine

Ofner M, Wonisch M, Frei M, Tschakert G, Domej W, Kröpfl JM, Hofmann P.
PMID: 25435769
J Sports Sci Med. 2014 Dec 01;13(4):774-81. eCollection 2014 Dec.

The goal of this study is to evaluate the response of physiological variables to acute normobaric hypoxia compared to normoxia and its influence on the lactate turn point determination according to the three-phase model of energy supply (Phase I:...

Cite
Ofner M, Wonisch M, Frei M, et al. Influence of acute normobaric hypoxia on physiological variables and lactate turn point determination in trained men. J Sports Sci Med. 2014;13(4):774-81
Ofner, M., Wonisch, M., Frei, M., Tschakert, G., Domej, W., Kröpfl, J. M., & Hofmann, P. (2014). Influence of acute normobaric hypoxia on physiological variables and lactate turn point determination in trained men. Journal of sports science & medicine, 13(4), 774-81.
Ofner, Michael, et al. "Influence of acute normobaric hypoxia on physiological variables and lactate turn point determination in trained men." Journal of sports science & medicine vol. 13,4 (2014): 774-81.
Ofner M, Wonisch M, Frei M, Tschakert G, Domej W, Kröpfl JM, Hofmann P. Influence of acute normobaric hypoxia on physiological variables and lactate turn point determination in trained men. J Sports Sci Med. 2014 Dec 01;13(4):774-81. eCollection 2014 Dec. PMID: 25435769; PMCID: PMC4234946.
Copy Download .nbib Format: NLM
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Schackert C, Korting HC, Schäfer-Korting M.
PMID: 18034533
BioDrugs. 2000 Apr;13(4):267-77. doi: 10.2165/00063030-200013040-00005.

Corticosteroids are widely used for the treatment of inflammatory skin disorders. However, systemic and local adverse drug reactions, especially skin atrophy, are potential complications that limit their use. Several attempts have been made to increase the safety of topical...

Cite
Schackert C, Korting HC, Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs. 2000;13(4):267-77doi: 10.2165/00063030-200013040-00005.
Schackert, C., Korting, H. C., & Schäfer-Korting, M. (2000). Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 13(4), 267-77. https://doi.org/10.2165/00063030-200013040-00005
Schackert, C, et al. "Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 13,4 (2000): 267-77. doi: https://doi.org/10.2165/00063030-200013040-00005
Schackert C, Korting HC, Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs. 2000 Apr;13(4):267-77. doi: 10.2165/00063030-200013040-00005. PMID: 18034533.
Copy Download .nbib Format: NLM
The Problem of Metal Needles in Acupuncture-fMRI Studies.

Evidence-based complementary and alternative medicine : eCAM

Beissner F, Nöth U, Schockert T.
PMID: 21423640
Evid Based Complement Alternat Med. 2011;2011:808203. doi: 10.1155/2011/808203. Epub 2011 Mar 01.

Acupuncture is a therapy based on sensory stimulation of the human body by means of metal needles. The exact underlying mechanisms of acupuncture have not been clarified so far. Functional magnetic resonance imaging (fMRI) has become an important tool...

Cite
Beissner F, Nöth U, Schockert T. The Problem of Metal Needles in Acupuncture-fMRI Studies. Evid Based Complement Alternat Med. 2011;2011:808203doi: 10.1155/2011/808203.
Beissner, F., Nöth, U., & Schockert, T. (2011). The Problem of Metal Needles in Acupuncture-fMRI Studies. Evidence-based complementary and alternative medicine : eCAM, 2011808203. https://doi.org/10.1155/2011/808203
Beissner, Florian, et al. "The Problem of Metal Needles in Acupuncture-fMRI Studies." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011): 808203. doi: https://doi.org/10.1155/2011/808203
Beissner F, Nöth U, Schockert T. The Problem of Metal Needles in Acupuncture-fMRI Studies. Evid Based Complement Alternat Med. 2011;2011:808203. doi: 10.1155/2011/808203. Epub 2011 Mar 01. PMID: 21423640; PMCID: PMC3057644.
Copy Download .nbib Format: NLM
Three-wave mixing with three incoming waves: signal-idler coherent attenuation and gain enhancement in a parametric amplifier.

Physical review letters

Schackert F, Roy A, Hatridge M, Devoret MH, Stone AD.
PMID: 23992068
Phys Rev Lett. 2013 Aug 16;111(7):073903. doi: 10.1103/PhysRevLett.111.073903. Epub 2013 Aug 16.

We demonstrate the time-reversed process of nondegenerate three-wave parametric amplification from three distinct sources in the fully nonlinear regime using a Josephson amplifier. In the reverse process, coherent attenuation, signal and idler beams destructively interfere in the presence of...

Cite
Schackert F, Roy A, Hatridge M, et al. Three-wave mixing with three incoming waves: signal-idler coherent attenuation and gain enhancement in a parametric amplifier. Phys Rev Lett. 2013;111(7):073903doi: 10.1103/PhysRevLett.111.073903.
Schackert, F., Roy, A., Hatridge, M., Devoret, M. H., & Stone, A. D. (2013). Three-wave mixing with three incoming waves: signal-idler coherent attenuation and gain enhancement in a parametric amplifier. Physical review letters, 111(7), 073903. https://doi.org/10.1103/PhysRevLett.111.073903
Schackert, Flavius, et al. "Three-wave mixing with three incoming waves: signal-idler coherent attenuation and gain enhancement in a parametric amplifier." Physical review letters vol. 111,7 (2013): 073903. doi: https://doi.org/10.1103/PhysRevLett.111.073903
Schackert F, Roy A, Hatridge M, Devoret MH, Stone AD. Three-wave mixing with three incoming waves: signal-idler coherent attenuation and gain enhancement in a parametric amplifier. Phys Rev Lett. 2013 Aug 16;111(7):073903. doi: 10.1103/PhysRevLett.111.073903. Epub 2013 Aug 16. PMID: 23992068.
Copy Download .nbib Format: NLM
Quantum back-action of an individual variable-strength measurement.

Science (New York, N.Y.)

Hatridge M, Shankar S, Mirrahimi M, Schackert F, Geerlings K, Brecht T, Sliwa KM, Abdo B, Frunzio L, Girvin SM, Schoelkopf RJ, Devoret MH.
PMID: 23307736
Science. 2013 Jan 11;339(6116):178-81. doi: 10.1126/science.1226897.

Measuring a quantum system can randomly perturb its state. The strength and nature of this back-action depend on the quantity that is measured. In a partial measurement performed by an ideal apparatus, quantum physics predicts that the system remains...

Cite
Hatridge M, Shankar S, Mirrahimi M, et al. Quantum back-action of an individual variable-strength measurement. Science. 2013;339(6116):178-81doi: 10.1126/science.1226897.
Hatridge, M., Shankar, S., Mirrahimi, M., Schackert, F., Geerlings, K., Brecht, T., Sliwa, K. M., Abdo, B., Frunzio, L., Girvin, S. M., Schoelkopf, R. J., & Devoret, M. H. (2013). Quantum back-action of an individual variable-strength measurement. Science (New York, N.Y.), 339(6116), 178-81. https://doi.org/10.1126/science.1226897
Hatridge, M, et al. "Quantum back-action of an individual variable-strength measurement." Science (New York, N.Y.) vol. 339,6116 (2013): 178-81. doi: https://doi.org/10.1126/science.1226897
Hatridge M, Shankar S, Mirrahimi M, Schackert F, Geerlings K, Brecht T, Sliwa KM, Abdo B, Frunzio L, Girvin SM, Schoelkopf RJ, Devoret MH. Quantum back-action of an individual variable-strength measurement. Science. 2013 Jan 11;339(6116):178-81. doi: 10.1126/science.1226897. PMID: 23307736.
Copy Download .nbib Format: NLM
Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma.

Cancers

Meneceur S, Linge A, Meinhardt M, Hering S, Löck S, Bütof R, Krex D, Schackert G, Temme A, Baumann M, Krause M, von Neubeck C.
PMID: 32260145
Cancers (Basel). 2020 Apr 03;12(4). doi: 10.3390/cancers12040871.

Glioblastoma is an aggressive brain tumour with a patient median survival of approximately 14 months. The development of innovative treatment strategies to increase the life span and quality of life of patients is hence essential. This requires the use...

Cite
Meneceur S, Linge A, Meinhardt M, et al. Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers (Basel). 2020;12(4)doi: 10.3390/cancers12040871.
Meneceur, S., Linge, A., Meinhardt, M., Hering, S., Löck, S., Bütof, R., Krex, D., Schackert, G., Temme, A., Baumann, M., Krause, M., & von Neubeck, C. (2020). Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers, 12(4), . https://doi.org/10.3390/cancers12040871
Meneceur, Sarah, et al. "Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma." Cancers vol. 12,4 (2020). doi: https://doi.org/10.3390/cancers12040871
Meneceur S, Linge A, Meinhardt M, Hering S, Löck S, Bütof R, Krex D, Schackert G, Temme A, Baumann M, Krause M, von Neubeck C. Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma. Cancers (Basel). 2020 Apr 03;12(4). doi: 10.3390/cancers12040871. PMID: 32260145; PMCID: PMC7226316.
Copy Download .nbib Format: NLM
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19.

EClinicalMedicine

Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ.
PMID: 34195577
EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul.

BACKGROUND: The SARS-CoV-2 virus enters cells via Angiotensin-converting enzyme 2 (ACE2), disrupting the renin-angiotensin-aldosterone axis, potentially contributing to lung injury. Treatment with angiotensin receptor blockers (ARBs), such as losartan, may mitigate these effects, though induction of ACE2 could increase...

Cite
Puskarich MA, Cummins NW, Ingraham NE, et al. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021;37:100957doi: 10.1016/j.eclinm.2021.100957.
Puskarich, M. A., Cummins, N. W., Ingraham, N. E., Wacker, D. A., Reilkoff, R. A., Driver, B. E., Biros, M. H., Bellolio, F., Chipman, J. G., Nelson, A. C., Beckman, K., Langlois, R., Bold, T., Aliota, M. T., Schacker, T. W., Voelker, H. T., Murray, T. A., Koopmeiners, J. S., & Tignanelli, C. J. (2021). A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine, 37100957. https://doi.org/10.1016/j.eclinm.2021.100957
Puskarich, Michael A, et al. "A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19." EClinicalMedicine vol. 37 (2021): 100957. doi: https://doi.org/10.1016/j.eclinm.2021.100957
Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul. PMID: 34195577; PMCID: PMC8225661.
Copy Download .nbib Format: NLM
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.

Neuropathology and applied neurobiology

Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skjøth-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T.
PMID: 34799864
Neuropathol Appl Neurobiol. 2021 Nov 19; doi: 10.1111/nan.12773. Epub 2021 Nov 19.

TERT promoter mutations have been associated with increased risk of recurrence in meningioma cohorts, thus a potential biomarker for aggressive phenotypes. A main purpose of refining tumour classification is better predictions on the patient level. We compiled data from...

Cite
Mirian C, Grell K, Juratli TA, et al. Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. Neuropathol Appl Neurobiol. 2021;doi: 10.1111/nan.12773.
Mirian, C., Grell, K., Juratli, T. A., Sahm, F., Spiegl-Kreinecker, S., Peyre, M., Biczok, A., Tonn, J. C., Goutagny, S., Bertero, L., Maier, A. D., Jensen, L. R., Schackert, G., Broholm, H., Scheie, D., Cahill, D. P., Brastianos, P. K., Skjøth-Rasmussen, J., Fugleholm, K., Ziebell, M., Munch, T. N., Kristensen, B. W., & Mathiesen, T. (2021). Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. Neuropathology and applied neurobiology, . https://doi.org/10.1111/nan.12773
Mirian, Christian, et al. "Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma." Neuropathology and applied neurobiology vol. (2021). doi: https://doi.org/10.1111/nan.12773
Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skjøth-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T. Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma. Neuropathol Appl Neurobiol. 2021 Nov 19; doi: 10.1111/nan.12773. Epub 2021 Nov 19. PMID: 34799864.
Copy Download .nbib Format: NLM
Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development.

Innovative surgical sciences

Salchow-Gille M, Rieger B, Reinshagen C, Molcanyi M, Lemke J, Brautferger U, Sitoci-Ficici KH, Polanski W, Pinzer T, Schackert G.
PMID: 34966835
Innov Surg Sci. 2021 Apr 07;6(1):11-24. doi: 10.1515/iss-2019-1002. eCollection 2021 Mar.

OBJECTIVES: The most important goal of surgical treatment for spinal degeneration, in addition to eliminating the underlying pathology, is to preserve the biomechanically relevant structures. If degeneration destroys biomechanics, the single segment must either be surgically stabilized or functionally...

Cite
Salchow-Gille M, Rieger B, Reinshagen C, et al. Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development. Innov Surg Sci. 2021;6(1):11-24doi: 10.1515/iss-2019-1002.
Salchow-Gille, M., Rieger, B., Reinshagen, C., Molcanyi, M., Lemke, J., Brautferger, U., Sitoci-Ficici, K. H., Polanski, W., Pinzer, T., & Schackert, G. (2021). Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development. Innovative surgical sciences, 6(1), 11-24. https://doi.org/10.1515/iss-2019-1002
Salchow-Gille, Monique, et al. "Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development." Innovative surgical sciences vol. 6,1 (2021): 11-24. doi: https://doi.org/10.1515/iss-2019-1002
Salchow-Gille M, Rieger B, Reinshagen C, Molcanyi M, Lemke J, Brautferger U, Sitoci-Ficici KH, Polanski W, Pinzer T, Schackert G. Prospective surgical solutions in degenerative spine: spinal simulation for optimal choice of implant and targeted device development. Innov Surg Sci. 2021 Apr 07;6(1):11-24. doi: 10.1515/iss-2019-1002. eCollection 2021 Mar. PMID: 34966835; PMCID: PMC8668033.
Copy Download .nbib Format: NLM
Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs.

Cancers

Seifert M, Schackert G, Temme A, Schröck E, Deutsch A, Klink B.
PMID: 32604718
Cancers (Basel). 2020 Jun 26;12(6). doi: 10.3390/cancers12061696.

Astrocytomas are primary human brain tumors including diffuse or anaplastic astrocytomas that develop towards secondary glioblastomas over time. However, only little is known about molecular alterations that drive this progression. We measured multi-omics profiles of patient-matched astrocytoma pairs of...

Cite
Seifert M, Schackert G, Temme A, et al. Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs. Cancers (Basel). 2020;12(6)doi: 10.3390/cancers12061696.
Seifert, M., Schackert, G., Temme, A., Schröck, E., Deutsch, A., & Klink, B. (2020). Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs. Cancers, 12(6), . https://doi.org/10.3390/cancers12061696
Seifert, Michael, et al. "Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs." Cancers vol. 12,6 (2020). doi: https://doi.org/10.3390/cancers12061696
Seifert M, Schackert G, Temme A, Schröck E, Deutsch A, Klink B. Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs. Cancers (Basel). 2020 Jun 26;12(6). doi: 10.3390/cancers12061696. PMID: 32604718; PMCID: PMC7352509.
Copy Download .nbib Format: NLM
Two-mode correlation of microwave quantum noise generated by parametric down-conversion.

Physical review letters

Bergeal N, Schackert F, Frunzio L, Devoret MH.
PMID: 22540583
Phys Rev Lett. 2012 Mar 23;108(12):123902. doi: 10.1103/PhysRevLett.108.123902. Epub 2012 Mar 21.

In this Letter, we report the observation of the correlation between two modes of microwave radiation resulting from the amplification of quantum noise by the Josephson parametric converter. This process, seen from the pump, can be viewed as parametric...

Cite
Bergeal N, Schackert F, Frunzio L, et al. Two-mode correlation of microwave quantum noise generated by parametric down-conversion. Phys Rev Lett. 2012;108(12):123902doi: 10.1103/PhysRevLett.108.123902.
Bergeal, N., Schackert, F., Frunzio, L., & Devoret, M. H. (2012). Two-mode correlation of microwave quantum noise generated by parametric down-conversion. Physical review letters, 108(12), 123902. https://doi.org/10.1103/PhysRevLett.108.123902
Bergeal, N, et al. "Two-mode correlation of microwave quantum noise generated by parametric down-conversion." Physical review letters vol. 108,12 (2012): 123902. doi: https://doi.org/10.1103/PhysRevLett.108.123902
Bergeal N, Schackert F, Frunzio L, Devoret MH. Two-mode correlation of microwave quantum noise generated by parametric down-conversion. Phys Rev Lett. 2012 Mar 23;108(12):123902. doi: 10.1103/PhysRevLett.108.123902. Epub 2012 Mar 21. PMID: 22540583.
Copy Download .nbib Format: NLM
Neurosurgical subspecialization: pros and cons.

Acta neurochirurgica

Schackert G, Reulen HJ.
PMID: 12820039
Acta Neurochir (Wien). 2003 May;145(5):337-40. doi: 10.1007/s00701-003-0042-1.

No abstract available.

Cite
Schackert G, Reulen HJ. Neurosurgical subspecialization: pros and cons. Acta Neurochir (Wien). 2003;145(5):337-40doi: 10.1007/s00701-003-0042-1.
Schackert, G., & Reulen, H. J. (2003). Neurosurgical subspecialization: pros and cons. Acta neurochirurgica, 145(5), 337-40. https://doi.org/10.1007/s00701-003-0042-1
Schackert, G, and Reulen, H-J. "Neurosurgical subspecialization: pros and cons." Acta neurochirurgica vol. 145,5 (2003): 337-40. doi: https://doi.org/10.1007/s00701-003-0042-1
Schackert G, Reulen HJ. Neurosurgical subspecialization: pros and cons. Acta Neurochir (Wien). 2003 May;145(5):337-40. doi: 10.1007/s00701-003-0042-1. PMID: 12820039.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries